Needham Reiterates a Buy Rating on Autolus Therapeutics (AUTL), Keeps the PT at $10
The analyst cited the promising results of the FELIX study for obe-cel in patients with relapsed/refractory acute lymphoblastic leukemia (ALL) as one of the factors supporting the optimistic rating, stating that the updated analysis highlights a notable number of patients in remission with no need for further therapy. This is a positive indicator, according to the analyst, especially in comparison to other treatments such as Tecartus.
A laboratory technician carefully studying a microscope with a biopharmaceutical product inside.
While the analyst acknowledged that 38% of responders were still in remission with a median follow-up of 33 months, a slight drop from the 40% reported at 21.5 months, he stated that the results are still impressive. He also cited other promising factors, including the overall survival and event-free survival rates, as well as the absence of new safety concerns.
According to Blum, these factors suggest a positive reception from physicians and the potential for higher commercial adoption of obe-cel, supporting the optimistic outlook for Autolus Therapeutics plc (NASDAQ:AUTL).
Autolus Therapeutics (NASDAQ:AUTL) is a clinical-stage biopharmaceutical company based in the United Kingdom. It develops programmed T cell therapies for treating autoimmune diseases and cancer, with a focus on chimeric antigen receptor (CAR) T cell therapy.
The company engineers controlled, targeted, and highly active T cell therapy product candidates designed to recognize target cells, break their defense mechanisms down, and eliminate them. It is doing so using a portfolio of proprietary and modular T-cell programming technologies.
While we acknowledge the potential of AUTL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.
Disclosure: None.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
14 minutes ago
- Yahoo
Prediction: Buying MercadoLibre Today Could Set You Up for Life
Key Points MercadoLibre is one of the world's fastest growing e-commerce companies. It has plenty of room to grow in Latin America. It still looks reasonably valued relative to its long-term growth potential. 10 stocks we like better than MercadoLibre › MercadoLibre (NASDAQ: MELI), Latin America's largest e-commerce company, went public at $18 a share in 2007. Today, its stock trades at about $2,330. That 12,844% gain would have turned a $10,000 investment into $1.29 million. From 2007 to 2024, MercadoLibre's annual revenue grew at a stunning CAGR of 38%. It established a first mover's advantage in Latin America's fertile e-commerce market, expanded its logistics network across the region's challenging terrain, and locked its shoppers into its Mercado Pago digital payments platform and other fintech services. MercadoLibre also turned profitable again in 2021, and its annual net income increased at a whopping CAGR of 184% over the following three years. Its profits surged as it sold more higher-margin products on its first-party marketplace, generated higher-margin revenue from its third-party marketplace, expanded its higher-margin credit and advertising segments, and leveraged its economies of scale to dilute its logistics, payment processing, and marketing expenses. Those growth rates are incredible, but some investors might be reluctant to buy MercadoLibre's stock after those multibagger gains. However, I believe buying MercadoLibre's stock today could still set you up for life for three simple reasons. 1. It hasn't saturated its core markets yet MercadoLibre operates its marketplace in 19 Latin American countries. However, it generates most of its revenue in Brazil, Argentina, and Mexico -- and it still has plenty of room to grow in smaller markets like Chile, Colombia, Peru, and Ecuador. At the end of 2024, MercadoLibre served more than 100 million annual unique active buyers and 60 million fintech monthly active users. But that's just a fraction of the 668 million people (including 451 million adults) who live in the Latin American and Caribbean region. Latin America's population is also expected to keep growing through 2050. That low penetration rate gives MercadoLibre plenty of room to expand its e-commerce and fintech platforms. Grand View Research expects Latin America's e-commerce market to grow at a CAGR of 16.7% from 2024 to 2030. IMARC Group predicts the region's fintech market will expand at a CAGR of 15.9% from 2025 to 2033. If MercadoLibre stays at the top of those booming markets, it will likely generate double-digit sales growth for the foreseeable future. 2. It's growing a lot faster than its overseas competitors From 2024 to 2027, analysts expect MercadoLibre's revenue and EPS to grow at a CAGR of 27% and 34%, respectively. That makes it one of the world's fastest-growing e-commerce companies. By comparison, analysts expect Amazon (NASDAQ: AMZN) and Sea Limited (NYSE: SE) -- which both tried in vain to challenge MercadoLibre in Latin America -- to grow their revenue at a CAGR of 11% and 21%, respectively, from 2024 to 2027. 3. It looks reasonably valued relative to its growth potential MercadoLibre's stock has already rallied nearly 40% this year, but it still doesn't seem too pricey relative to its e-commerce peers at 35 times next year's earnings. Amazon trades at 29 times forward earnings, while Sea trades at a higher forward multiple of 40. MercadoLibre's valuations are likely being compressed by the near-term concerns about tariffs, inflation, and political unrest across several of its top markets. The devaluation of Latin American currencies against the U.S. dollar (in which MercadoLibre reports its earnings) could be exacerbating that pressure. But if those headwinds eventually dissipate, MercadoLibre's stock could command a much higher valuation again. How much bigger could MercadoLibre grow? Assuming MercadoLibre matches analysts' expectations through 2027, grows its EPS at a robust CAGR of 20% over the following 18 years, and trades at a reasonable 30 times earnings by the final year, its stock price could potentially climb more than 30 times to $71,480 by 2045. That price target sounds high, but it would only boost its market cap to $3.6 trillion. For reference, Amazon currently has a market cap of $2.4 trillion -- and it will likely be worth a lot more in 20 years. Therefore, if you expect MercadoLibre to maintain its leading position in Latin America's e-commerce and fintech markets, expand its margins as it scales up its business, and weather the region's near-term macro headwinds, then it's still an excellent long-term buy. Should you invest $1,000 in MercadoLibre right now? Before you buy stock in MercadoLibre, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and MercadoLibre wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $668,155!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,106,071!* Now, it's worth noting Stock Advisor's total average return is 1,070% — a market-crushing outperformance compared to 184% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 13, 2025 Leo Sun has positions in Amazon and MercadoLibre. The Motley Fool has positions in and recommends Amazon, MercadoLibre, and Sea Limited. The Motley Fool has a disclosure policy. Prediction: Buying MercadoLibre Today Could Set You Up for Life was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
CNBC
16 minutes ago
- CNBC
Conservative network Newsmax agrees to pay $67 million in defamation case over bogus 2020 election claims
The conservative network Newsmax will pay $67 million to settle a lawsuit accusing it of defaming a voting equipment company by spreading lies about President Donald Trump's 2020 election loss, according to documents filed Monday. The settlement comes after Fox News Channel paid $787.5 million to settle a similar lawsuit in 2023 and Newsmax paid what court papers describe as $40 million to settle a libel lawsuit from a different voting machine manufacturer, Smartmatic, which also was a target of pro-Trump conspiracy theories on the network. Delaware Superior Court Judge Eric Davis had ruled earlier that Newsmax did indeed defame Denver-based Dominion Voting Systems by airing false information about the company and its equipment. But Davis left it to a jury to eventually decide whether that was done with malice, and, if so, how much Dominion deserved from Newsmax in damages. Newsmax and Dominion reached a settlement before the trial could take place. The settlement was disclosed by Newsmax on Monday in a new filing with the U.S. Securities and Exchange Commission. It said the deal was reached Friday. A spokesperson for Dominion said the company was pleased to have settled the lawsuit. The disclosure came as Trump, who lost his 2020 reelection bid to Democrat Joe Biden, vowed in a social media post Monday to eliminate mail-in ballots and voting machines such as those supplied by Dominion and other companies. It was unclear how the Republican president could achieve that. The same judge also handled the Dominion-Fox News case and made a similar ruling that the network repeated numerous lies by Trump's allies about his 2020 loss despite internal communications showing Fox officials knew the claims were bogus. At the time, Davis found it was "CRYSTAL clear" that none of the allegations was true. Internal correspondence from Newsmax officials likewise shows they knew the claims were baseless. "How long are we going to play along with election fraud?" Newsmax host Bob Sellers said two days after the 2020 election was called for Biden, according to internal documents revealed as part of the case. Newsmax took pride that it was not calling the election for Biden and, the internal documents show, saw a business opportunity in catering to viewers who believed Trump won. Private communications that surfaced as part of Dominion's earlier defamation case against Fox News also revealed how the network's business interests intersected with decisions it made related to coverage of Trump's 2020 election claims. At Newsmax, employees repeatedly warned against false allegations from pro-Trump guests such as attorney Sidney Powell, according to documents in the lawsuit. In one text, even Newsmax owner Chris Ruddy, a Trump ally, said he found it "scary" that Trump was meeting with Powell. Dominion was at the heart of many of the wild claims aired by guests on Newsmax and elsewhere, who promoted a conspiracy theory involving deceased Venezuelan president Hugo Chavez to rig the machines for Biden. The network retracted some of the more bombastic allegations in December 2020. Though Trump has insisted his fraud claims are real, there's no evidence they were, and the lawsuits in the Fox and Newsmax cases show how some of the president's biggest supporters knew they were false at the time. Trump's then-attorney general, William Barr, said there was no evidence of widespread fraud. Trump and his backers lost dozens of lawsuits alleging fraud, some before Trump-appointed judges. Numerous recounts, reviews and audits of the election results, including some run by Republicans, turned up no signs of significant wrongdoing or error and affirmed Biden's win. After returning to office, Trump pardoned those who tried to halt the transfer of power during the Jan. 6, 2021, attack on the U.S. Capitol and directed his Department of Justice to investigate Chris Krebs, a former Trump cybersecurity appointee who had vouched for the security and accuracy of the 2020 election. As an initial trial date approached in the Dominion case earlier this year, Trump issued an executive order attacking the law firm that litigated it and the Fox case, Susman Godfrey. The order, part of a series targeting law firms Trump has tussled with, cited Susman Godfrey's work on elections and said the government would not do business with any of its clients or permit any of its staff in federal buildings. A federal judge put that action on hold, saying the framers would view it as "a shocking abuse of power. "
Business Insider
18 minutes ago
- Business Insider
Morning Movers: Dayforce surges after potential Thoma Bravo acquisition reports
Stock futures are drifting lower this morning as investors lean into a busy week headlined by Jackson Hole central bank speeches and earnings from major retailers. Small caps are showing outperformance, suggesting rotation after recent megacap strength, particularly in tech. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Geopolitical developments are adding weight as markets are monitoring the potential implications of President Trump's meeting with Ukrainian President Zelensky and European leaders as Washington seeks support for a Ukraine–Russia peace initiative. In pre-market trading, S&P 500 futures fell 0.09%, Nasdaq futures fell 0.14% and Dow futures are flat. Check out this morning's top movers from around Wall Street, compiled by The Fly, and subscribe to the Fly By if you want to know how the markets will open, which stocks will be moving and why. HIGHER – Dayforce (DAY) up 25% after Bloomberg reported Thoma Bravo is in talks to acquire the company Soho House (SHCO) up 16% after entering into definitive agreements pursuant to which an investor group led by MCR and its chairman and CEO Tyler Morse will acquire the outstanding shares not held by certain significant shareholders TeraWulf (WULF) up 11% after reporting Google (GOOGL) will provide an incremental backstop of $1.4B in support of project-related debt financing and will receive warrants to acquire shares of TeraWulf common stock Tonix Pharmaceuticals (TNXP) up 4% after announcing that the FDA approved Tonmya for the treatment of fibromyalgia in adults Novo Nordisk (NVO) up 4% after announcing that the FDA has approved an additional indication for Wegovy based on a supplemental New Drug Application for treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis in adults with moderate to advanced liver fibrosis DOWN AFTER EARNINGS – Riskified (RSKD) down 13% LOWER – Strategy (MSTR) and Coinbase (COIN) both down 1% after bitcoin dipped as heightened macro concerns triggered more than $500M in forced selling of long positions. Tesla (TSLA) down 1% after The Times reported British motorists can lease a Tesla EV for about half the cost it was a year ago as the company attempts to boost its faltering sales in the UK
